1.890
0.000
(0.00%)
As of January 24 at 10:08:57 AM GMT+8. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 0.09 | 0.12 |
| Low Estimate | 0 | 0 | 0.09 | 0.12 |
| High Estimate | 0 | 0 | 0.09 | 0.12 |
| Year Ago EPS | -- | -- | -- | 0.09 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 1.09B | 1.38B |
| Low Estimate | -- | -- | 1.09B | 1.38B |
| High Estimate | -- | -- | 1.09B | 1.38B |
| Year Ago Sales | -- | -- | -- | 1.09B |
| Sales Growth (year/est) | -- | -- | -- | 25.94% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.09 | 0.12 |
| 7 Days Ago | 0 | 0 | 0.09 | 0.12 |
| 30 Days Ago | 0 | 0 | 0.09 | 0.12 |
| 60 Days Ago | 0 | 0 | 0.09 | 0.12 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1875.HK | -- | -- | -- | 33.33% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Related Tickers
7754.TWO AnnJi
32.55
0.00%
2696.HK Shanghai Henlius Biotech, Inc.
16.820
-1.06%
7776.TWO Anya
37.35
+0.40%
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
8.50
+2.04%
4192.TWO SynCore Biotechnology Co.,Ltd
34.85
+2.20%
6696.TWO Lin BioScience, Inc.
152.00
+4.47%
6733.TWO BioGend Therapeutics Co., Ltd.
32.80
-0.30%
4726.TWO Mycenax Biotech Inc.
39.65
+0.38%
6838.TW Formosa Pharmaceuticals, Inc.
34.75
+2.06%
GMAB Genmab A/S
20.80
-1.56%